P Jiménez-Fonseca, A Carmona-Bayonas, C Font, J Plasencia-Martínez, D Calvo-Temprano, R Otero, C Beato, M Biosca, M Sánchez, M Benegas, D Varona, L Faez, M Antonio, I de la Haba, O Madridano, M P Solis, A Ramchandani, E Castañón, P J Marchena, M Martín, F Ayala de la Peña, V Vicente
AIM: To assess the prevalence and prognostic significance of additional intrathoracic findings (AIFs) in patients with cancer and pulmonary embolism (PE). AIFs were considered alterations other than the characteristic ones intrinsic to PE or changes in cardiovascular morphology. METHODS: Subjects have been taken from a Spanish national multidisciplinary and multicenter study of PE and cancer who were treated between 2004 and 2015. The endpoint was the appearance of serious complications or death within 15 days...
July 10, 2017: Clinical & Translational Oncology